USD22.45
Clinical proxy and integrity record: Athira Pharma's Phase 1 publications, the 77-participant ACT-AD Phase 2 trial, the SHAPE study in Parkinson's disease dementia and dementia with Lewy bodies, and Athira's September 3, 2024 topline announcement for the LIFT-AD Phase 2/3 trial of fosgonimeton (ATH-1017), which evaluated once-daily subcutaneous fosgonimeton 40 mg over a 26-week treatment period in a 312-patient primary analysis population of mild-to-moderate Alzheimer's patients not on acetylcholinesterase inhibitors and missed its primary and key secondary endpoints (GST change -0.08, p = 0.70) https://cdn.shopify.com/s/files/1/2461/7623/files/bpc-157-for-tendon-and-ligament-repair_1200x.png?v=1784826026 Healthcare Size:16 oz Peugeot e-208 Review 2026 | Top Gear
USD22.45
USD26.00
USD25.12
USD21.56
USD19.99
USD24.96
USD22.36
USD26.67
USD25.14
USD29.27
USD20.54
Ask the seller a focused question about the conflicting detail. Treat an unanswered question as uncertainty rather than implied confirmation.
Avoid opening unnecessary duplicate requests that could split the conversation. Use precise details about the actual purchase instead of assumptions about the cause.
Compare the checkout entry with the option you intended to choose. Review the product reference alongside its visible option name.